COVID-19 Vaccination Intentions: The Theory of Planned Behavior, Optimistic Bias, and Anticipated Regret

por Wolff, Katharina
Publicado 2021

A Terrible Future: Episodic Future Thinking and the Perceived Risk of Terrorism

por Bø, Simen, Wolff, Katharina
Publicado 2019

I Can See Clearly Now: Episodic Future Thinking and Imaginability in Perceptions of Climate-Related Risk Events

por Bø, Simen, Wolff, Katharina
Publicado 2020

What Makes Tourist Experiences Interesting

por Larsen, Svein, Wolff, Katharina, Doran, Rouven, Øgaard, Torvald
Publicado 2019

Complexity and Simplification in Understanding Travel Preferences Among Tourists

por Øgaard, Torvald, Doran, Rouven, Larsen, Svein, Wolff, Katharina
Publicado 2019

Feedback activation of neurofibromin terminates growth factor-induced Ras activation

por Hennig, Anne, Markwart, Robby, Wolff, Katharina, Schubert, Katja, Cui, Yan, Prior, Ian A., Esparza-Franco, Manuel A., Ladds, Graham, Rubio, Ignacio
Publicado 2016

Sumoylation of HDAC2 promotes NF-κB-dependent gene expression

por Wagner, Tobias, Kiweler, Nicole, Wolff, Katharina, Knauer, Shirley K., Brandl, André, Hemmerich, Peter, Dannenberg, Jan-Hermen, Heinzel, Thorsten, Schneider, Günter, Krämer, Oliver H.
Publicado 2015

Potent Antitumor Activity of Liposomal Irinotecan in an Organoid- and CRISPR-Cas9-Based Murine Model of Gallbladder Cancer

por Erlangga, Zulrahman, Wolff, Katharina, Poth, Tanja, Peltzer, Alexander, Nahnsen, Sven, Spielberg, Steffi, Timrott, Kai, Woller, Norman, Kühnel, Florian, Manns, Michael P., Saborowski, Anna, Vogel, Arndt, Saborowski, Michael
Publicado 2019

Murine Liver Organoids as a Genetically Flexible System to Study Liver Cancer In Vivo and In Vitro

por Saborowski, Anna, Wolff, Katharina, Spielberg, Steffi, Beer, Benedikt, Hartleben, Björn, Erlangga, Zulrahman, Becker, Diana, Dow, Lukas E., Marhenke, Silke, Woller, Norman, Unger, Kristian, Schirmacher, Peter, Manns, Michael P., Marquardt, Jens U., Vogel, Arndt, Saborowski, Michael
Publicado 2019

Exploratory analysis of front-line therapies in REVEL: a randomised phase 3 study of ramucirumab plus docetaxel versus docetaxel for the treatment of stage IV non-small-cell lung c...

por Garon, Edward B, Scagliotti, Giorgio Vittorio, Gautschi, Oliver, Reck, Martin, Thomas, Michael, Iglesias Docampo, Lara, Kalofonos, Haralabos, Kim, Joo-Hang, Gans, Steven, Brustugun, Odd Terje, Orlov, Sergey V, Cuyun Carter, Gebra, Zimmermann, Annamaria H, Oton, Ana B, Alexandris, Ekaterine, Lee, Pablo, Wolff, Katharina, Stefaniak, Victoria Jennifer, Socinski, Mark A, Pérol, Maurice
Publicado 2020